These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2179157)

  • 1. Reduction of circulating HIV antigens in seropositive patients after treatment with AL-721.
    Yust I; Vardinon N; Skornick Y; Zakuth V; Hasner A; Shinitzky M
    Isr J Med Sci; 1990 Jan; 26(1):20-6. PubMed ID: 2179157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of HIV antigenaemia by AL721.
    Shinitzky M; Skornick Y
    Lancet; 1990 May; 335(8700):1281-2. PubMed ID: 1971348
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of AIDS with AL-721.
    Klajman A
    Isr J Med Sci; 1990 Jan; 26(1):2-4. PubMed ID: 2179156
    [No Abstract]   [Full Text] [Related]  

  • 4. Ineffectiveness of AL721 in HIV disease.
    Peters BS; Bennett JM; Jeffries DJ; Knox K; Kocsis A; Pinching AJ
    Lancet; 1990 Mar; 335(8688):545-6. PubMed ID: 1968558
    [No Abstract]   [Full Text] [Related]  

  • 5. Open study of AL-721 treatment of HIV-infected subjects with generalized lymphadenopathy syndrome: an eight week open trial and follow-up.
    Grieco MH; Lange M; Buimovici-Klein E; Reddy MM; Englard A; McKinley GF; Ong K; Metroka C
    Antiviral Res; 1988 Apr; 9(3):177-90. PubMed ID: 2456739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label, dose-ranging trial of AL 721 in patients with persistent generalized lymphadenopathy and AIDS-related complex.
    Mildvan D; Buzas J; Armstrong D; Antoniskis D; Sacks HS; Rhame FS; Mosbach EW; Pettinelli C
    J Acquir Immune Defic Syndr (1988); 1991; 4(10):945-51. PubMed ID: 1890604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue.
    Mathé G; Pontiggia P; Orbach-Arbouys S; Triana K; Ambetima N; Morette C; Hallard M; Blanquet D
    Biomed Pharmacother; 1996; 50(5):220-7. PubMed ID: 8949403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic abnormalities related to antigenaemia during HIV-1 infection.
    De Paoli P; Battistin S; Crovatto M; Modolo ML; Carbone A; Tirelli U; Santini G
    Clin Exp Immunol; 1988 Dec; 74(3):317-20. PubMed ID: 2976619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIH-sponsored clinical trials begin for antiviral drug AL721.
    Bennett J
    Am J Nurs; 1988 Apr; 88(4):432. PubMed ID: 3279780
    [No Abstract]   [Full Text] [Related]  

  • 10. Zidovudine and lamivudine: results of phase III studies.
    Staszewski S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
    Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of virus isolation and antigen enzyme immunoassay in the detection of HIV].
    Barrett PN; Dorner F; Stingl G; Heinz FX; Kunz C
    Wien Klin Wochenschr; 1989 Jun; 101(13):446-7. PubMed ID: 2503943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversial AIDS drug for US market.
    Barinaga M
    Nature; 1988 Apr; 332(6164):475. PubMed ID: 3357506
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of alpha interferon levels by AZT treatment in HIV-seropositive patients.
    Buimovici-Klein E; McKinley GF; Lange M; Sonnabend JA; Mohan V; Grieco MH; Cooper LZ
    J Exp Pathol; 1992; 6(1-2):31-9. PubMed ID: 1625038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
    Plana M; Ferrer E; Martínez C; Podzamczer D; García F; Maleno MJ; Barceló JJ; García A; Barberá MJ; Lacarcel M; Miró JM; Gallart T; Gatell JM
    Antivir Ther; 2004 Apr; 9(2):197-204. PubMed ID: 15134181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live-cell immunofluorescence for detection of human immunodeficiency virus type 1 (HIV-1)-related antigens in peripheral blood mononuclear cells from HIV-1 seropositive individuals.
    Valensin PE; Zazzi M; Valassina M; Bianchi Bandinelli ML; Toti M; Almi P; Rubino M; Caruso A
    Microbiologica; 1989 Oct; 12(4):281-9. PubMed ID: 2685514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's-sarcoma-associated herpesvirus is detected in peripheral blood mononuclear cells of HIV-infected homosexuals more often than in heterosexuals.
    Rizzieri DA; Liu J; Miralles D; Traweek ST
    Cancer J Sci Am; 1997; 3(3):153-6. PubMed ID: 9161780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose oral alpha-interferon therapy for patients seropositive for human immunodeficiency virus type-1 (HIV-1).
    Koech DK; Obel AO; Minowada J; Hutchinson VA; Cummins JM
    Mol Biother; 1990 Jun; 2(2):91-5. PubMed ID: 1973045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of HIV antigens in cerebrospinal fluid and in serum of patients with both asymptomatic and symptomatic HIV infection].
    Radkowski M; Laskus T; Kopicz-Kamińska E; Mian M; Babiuch L; Slusarczyk J
    Pol Tyg Lek; 1992 Sep 7-14; 47(36-37):784-6. PubMed ID: 1293560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.